Japan's Kowa Says Ivermectin Has 'Antiviral Effect' Against Omicron, Other Variants

Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an “antiviral effect” against Omicron and other variants of coronavirus in joint non-clinical research.

Kowa did not provide further details. The firm has been working with Kitasato University, a medical university in Tokyo.

[link to www.usnews.com (secure)]